ATTR-CM Early Detection Educational Campaign

I led the development of an unbranded educational campaign designed to support earlier detection of ATTR-CM by aligning internal education with HCP-facing clinical education.

The campaign combined two complementary video experiences, each serving a distinct role—from introducing a new interactive tool internally to reinforcing clinical awareness externally.

ABE (Amyloid Body of Evidence) — Internal Education

The ABE video educated the internal sales force on a new interactive human body tool that visualizes ATTR amyloidosis as a systemic, multi-organ disease.

Through 3D-rendered anatomy and dynamic visualization, the video demonstrated how the tool works and how it can be used by sales representatives to introduce and explain the experience to HCPs, moving beyond a heart-only view of the disease.

EstimATTR — HCP Education

The EstimATTR video was created for HCP audiences to address challenges in delayed ATTR-CM diagnosis.

It highlighted common diagnostic barriers and red flags, encouraging earlier suspicion and positioning EstimATTR as an educational resource to support timely clinical consideration.

Together, the two videos functioned as a connected educational system—supporting consistent internal understanding while reinforcing earlier recognition of ATTR-CM in clinical practice.

Client: Pfizer